#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oropharyngeal cancer recurrent Renal cancer metastatic Giant cell tumour of tendon sheath Dilated cardiomyopathy Dementia Alzheimer's type Kearns-Sayre syndrome Cutaneous T-cell lymphoma refractory Prolymphocytic leukaemia Loeys-Dietz syndrome Infertility female Anti-neutrophil cytoplasmic antibody positive vasculitis Oesophageal carcinoma Multifocal motor neuropathy Chronic kidney disease Hypomagnesaemia More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy Glomerulonephritis rapidly progressive – Diagnostics Prolymphocytic leukaemia Propionic acidaemia – Trials in Disease Marfan’s syndrome – Treatment Aicardi-Goutieres syndrome – Life with Disease CADASIL – Diagnostics Idiopathic inflammatory myopathy – Diagnostics Small intestine leiomyosarcoma – Basic Information Anaplastic thyroid cancer – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Talquetamab Tulisokibart Landiolol Hydrochloride Eye103 Envudeucitinib Betaxolol Lorundrostat Gsk3858279 GSKVX000000034795 Moxifloxacin Cobolimab Naloxone Albiglutide HYPOCHLOROUS ACID Dronedarone ZUNIBERGENE ROCPARVOVEC Dexmedetomidine Hydrochloride Afm24 Eftilagimod Alfa Magnesium Oxybate More therapies…

    Learn about Your Condition

    Bronchitis Ventricular extrasystoles Cholecystitis acute B-cell type acute leukaemia Parkinson's disease Langerhans cell sarcoma Arrhythmia Uveitis Genitourinary tract neoplasm Drug eruption Nodal osteoarthritis Juvenile idiopathic arthritis Paraesthesia Acute cardiac event Cutaneous lupus erythematosus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Renal transplant

  • Study on Mannitol and Normal Saline for Patients with End-Stage Renal Disease Undergoing Kidney Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    • Renal transplant
    Investigated Drugs:
    • Mannitol
    Finland

  • Study on the Safety of Eight Treg and Drug Combination for Patients with Chronic Kidney Failure Undergoing Transplant from a Living Donor

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Renal transplant
    Investigated Drugs:
    • Eight Treg
    • Mycophenolic Acid
    • Methylprednisolone Hydrogen Succinate
    France

  • Study on Eplerenone for Improving Kidney Function in Patients Undergoing Kidney Transplantation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Eplerenone
    • Iohexol
    France

  • Study on the Effects of Belatacept, Ciclosporin, and Tacrolimus on Blood Vessel Health in Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Glyceryl Trinitrate
    • Belatacept
    • Ciclosporin
    France

  • Study on Optimal Dose of Rabbit Anti-Human T-Lymphocyte Immunoglobulin and Mycophenolic Acid for Kidney Transplant Patients with Low Immunological Risk

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal failure
    • Renal transplant
    Investigated Drugs:
    • Mycophenolic Acid
    France

  • Safety Study of Regulatory T Cells (Treg02) in Patients After Kidney Transplant

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Treg02
    • Valganciclovir Hydrochloride
    • Methylprednisolone Sodium Succinate
    Germany
Previous Page
1 2 3 4 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!